- 작성자 : ILIAS Biologics
- 작성일 : 20-01-29 18:46
- 조회 : 724회
29 Jan 2020
ILIAS Biologics Expands Leadership Team with the appointment of Taejin Ham as Chief Operating Officer & Jun Park as Chief Scientific Officer
Former CEO of Celgene Korea, Taejin Ham joins ILIAS Biologics as Executive Vice President, Chief Operating Officer. Prior to Celgene, he worked for Eli Lilly and Company in multiple leadership roles. Former US FDA Reviewer, Jun Park also joins ILIAS Biologics as Executive Vice President, Chief Scientific Officer. He served as an FDA reviewer for over 11 years in charge of evaluating the product quality and manufacturing process for biopharmaceutical products. With the addition of two executives, ILIAS is expecting to see the acceleration of the next stage of growth.
Press Link (Korean): http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239989